insights_auto
Why is ARGX down ४.०९%?
Dive Deeperchevron_right
ARGX:EBR
argenx SE
€ ७२७.६०
arrow_downward
-४.०९%(-३१.००) 1D
अक्टोबर १६, १७:३९:३५ GMT+२ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
€ ७५९.२०
High
€ ७६१.८०
Low
€ ७२७.६०
Mkt. cap
४८.३६ अरब
Avg. vol.
८६.९० हजार
Volume
९६.२५ हजार
P/E ratio
३०.९५
52-wk high
€ ९२५.००
52-wk low
€ ५६८.४०
EPS
€ २३.५१
Shares outstanding
३.५९ करोड
No. of employees
२ हजार
Open
€ ७५९.२०
High
€ ७६१.८०
Low
€ ७२७.६०
Mkt. cap
४८.३६ अरब
Avg. vol.
८६.९० हजार
Volume
९६.२५ हजार
P/E ratio
३०.९५
52-wk high
€ ९२५.००
52-wk low
€ ५६८.४०
EPS
€ २३.५१
Shares outstanding
३.५९ करोड
No. of employees
२ हजार
News stories
From web sources and news partners
ad-hoc-news.de
·
१ दिन पहिले
argenx reports trial results: what it means for argenx stock
TipRanks
·
१ दिन पहिले
Argenx Stock Stumbles As Trial Failure Haunts Rally
ad-hoc-news.de
·
२ दिन पहिले
Goldman lifts target for Argenx stock to EUR 959.00
Yahoo Finance
·
२ दिन पहिले
Zacks Investment Ideas feature highlights: Cummins, Argenx and PACCAR
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE